Sarepta Therapeutics
Andrea Skirda has extensive experience in regulatory affairs and quality control within the biopharmaceutical sector, currently serving as Senior Manager of CMC Regulatory Affairs and Gene Therapy Quality Control at Sarepta Therapeutics since October 2017. Previous roles at Sarepta include Manager and Quality Control Lead in Gene Therapy Quality Control. Prior to this, Andrea worked at Nitto Denko Avecia Inc. as Quality Control Analyst II and I, focusing on cGMP stability and release testing. Andrea's experience also includes a position as QA/QC Technician at AG Hair, where analysis of compliance with SOPs was performed, and a contract role as Documentation for Operations Coordinator at CB&I. An internship in Chemical Research and Development at BASF provided foundational experience in laboratory techniques. Andrea holds a Bachelor of Science in Chemistry from the University of Victoria, obtained in 2013.
This person is not in any teams
This person is not in any offices
Sarepta Therapeutics
11 followers
Sarepta Therapeutics, headquartered in Cambridge, Massachusetts, is a global biotechnology company on an urgent mission: engineer precision genetic medicine for rare diseases that devastate lives and cut futures short.